Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 5490

1.

Autoantibodies to GM1 and GQ1bα are not Biological Markers of Alzheimer's Disease.

Miura Y, Miyaji K, Chai YL, Chen CL, Lai MK, Yuki N.

J Alzheimers Dis. 2014 Jul 11. [Epub ahead of print]

PMID:
25024341
[PubMed - as supplied by publisher]
2.

Depression in Mild Cognitive Impairment is associated with Progression to Alzheimer's Disease: A Longitudinal Study.

Van der Mussele S, Fransen E, Struyfs H, Luyckx J, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S.

J Alzheimers Dis. 2014 Jul 7. [Epub ahead of print]

PMID:
25024328
[PubMed - as supplied by publisher]
3.

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

Gabelle A, Schraen S, Gutierrez LA, Pays C, Rouaud O, Buée L, Touchon J, Helmer C, Lambert JC, Berr C.

Alzheimers Dement. 2014 Jul 8. pii: S1552-5260(14)00643-8. doi: 10.1016/j.jalz.2014.04.515. [Epub ahead of print]

PMID:
25022539
[PubMed - as supplied by publisher]
4.

Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.

Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P.

J Neuroinflammation. 2014 Jul 8;11(1):120. doi: 10.1186/1742-2094-11-120.

PMID:
25005532
[PubMed - in process]
Free PMC Article
5.

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.

Kleinberger G, Yamanishi Y, Suárez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, Tahirovic S, Lleó A, Alcolea D, Fortea J, Willem M, Lammich S, Molinuevo JL, Sánchez-Valle R, Antonell A, Ramirez A, Heneka MT, Sleegers K, van der Zee J, Martin JJ, Engelborghs S, Demirtas-Tatlidede A, Zetterberg H, Van Broeckhoven C, Gurvit H, Wyss-Coray T, Hardy J, Colonna M, Haass C.

Sci Transl Med. 2014 Jul 2;6(243):243ra86. doi: 10.1126/scitranslmed.3009093.

PMID:
24990881
[PubMed - in process]
6.

Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.

Van der Mussele S, Le Bastard N, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S.

Aging Ment Health. 2014 Jun 25:1-11. [Epub ahead of print]

PMID:
24962058
[PubMed - as supplied by publisher]
7.

The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review.

Chang YT, Chang WN, Tsai NW, Huang CC, Kung CT, Su YJ, Lin WC, Cheng BC, Su CM, Chiang YF, Lu CH.

Biomed Res Int. 2014;2014:182303. doi: 10.1155/2014/182303. Epub 2014 May 14.

PMID:
24949424
[PubMed - in process]
Free PMC Article
8.

Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.

Silva AR, Santos AC, Farfel JM, Grinberg LT, Ferretti RE, Campos AH, Cunha IW, Begnami MD, Rocha RM, Carraro DM, de Bragança Pereira CA, Jacob-Filho W, Brentani H.

PLoS One. 2014 Jun 17;9(6):e99897. doi: 10.1371/journal.pone.0099897. eCollection 2014.

PMID:
24936870
[PubMed - in process]
Free PMC Article
9.

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL.

Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0.

PMID:
24849862
[PubMed - indexed for MEDLINE]
10.

Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.

Kim DH, Yeo SH, Park JM, Choi JY, Lee TH, Park SY, Ock MS, Eo J, Kim HS, Cha HJ.

Gene. 2014 Jul 25;545(2):185-93. doi: 10.1016/j.gene.2014.05.031. Epub 2014 May 15. Review.

PMID:
24838203
[PubMed - indexed for MEDLINE]
11.

Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease.

Alcolea D, Carmona-Iragui M, Suárez-Calvet M, Sánchez-Saudinós MB, Sala I, Antón-Aguirre S, Blesa R, Clarimón J, Fortea J, Lleó A.

J Alzheimers Dis. 2014 May 12. [Epub ahead of print]

PMID:
24820015
[PubMed - as supplied by publisher]
12.

Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.

Lista S, Zetterberg H, Dubois B, Blennow K, Hampel H.

J Neurol. 2014 Jun;261(6):1234-43. doi: 10.1007/s00415-014-7366-z. Epub 2014 May 8.

PMID:
24807087
[PubMed - in process]
13.

[Biological markers for early diagnosis of Alzheimer's disease].

Taniguchi M, Urakami K.

Rinsho Byori. 2014 Mar;62(3):261-6. Japanese.

PMID:
24800502
[PubMed - in process]
14.

[Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy].

Shoji M.

Nihon Naika Gakkai Zasshi. 2014 Mar 10;103(3):630-6. Review. Japanese. No abstract available.

PMID:
24796129
[PubMed - indexed for MEDLINE]
15.

Analysis of combined CSF biomarkers in AD diagnosis.

De Riva V, Galloni E, Marcon M, Di Dionisio L, Deluca C, Meligrana L, Bolner A, Perini F.

Clin Lab. 2014;60(4):629-34.

PMID:
24779297
[PubMed - indexed for MEDLINE]
16.

Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.

Saman S, Lee NC, Inoyo I, Jin J, Li Z, Doyle T, McKee AC, Hall GF.

J Alzheimers Dis. 2014;40 Suppl 1:S47-70. doi: 10.3233/JAD-132135.

PMID:
24718102
[PubMed - in process]
17.

Validation of the AD-CSF-Index in Autopsy-Confirmed Alzheimer's Disease Patients and Healthy Controls.

Struyfs H, Molinuevo JL, Martin JJ, De Deyn PP, Engelborghs S.

J Alzheimers Dis. 2014 Apr 4. [Epub ahead of print]

PMID:
24705548
[PubMed - as supplied by publisher]
18.

The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.

Danborg PB, Simonsen AH, Waldemar G, Heegaard NH.

Biomarkers. 2014 Jun;19(4):259-68. doi: 10.3109/1354750X.2014.904001. Epub 2014 Mar 29.

PMID:
24678935
[PubMed - in process]
19.

Biological markers of Alzheimer's disease.

de Souza LC, Sarazin M, Teixeira-Júnior AL, Caramelli P, dos Santos AE, Dubois B.

Arq Neuropsiquiatr. 2014 Mar;72(3):227-31.

PMID:
24676441
[PubMed - in process]
Free Article
20.

Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.

Di Domenico F, Pupo G, Tramutola A, Giorgi A, Schininà ME, Coccia R, Head E, Butterfield DA, Perluigi M.

Free Radic Biol Med. 2014 Jun;71:270-80. doi: 10.1016/j.freeradbiomed.2014.03.027. Epub 2014 Mar 25.

PMID:
24675226
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk